Joyce Liu, MD
Disclosures: Consulting Fee-AstraZeneca (Relationship has ended)|Consulting Fee-Clovis Oncology (Relationship has ended)|Consulting Fee-Eisai, Inc. (Relationship has ended)|Consulting Fee-EpsilaBio (Relationship has ended)|Consulting Fee-Genentech, Inc. (Relationship has ended)|Consulting Fee-Regeneron therapeutics (Relationship has ended)|Consulting Fee-GlaxoSmithKline (Relationship has ended) - 07/15/2022
No Bio Available.